The HFD mice had higher protein levels of APP, Tau, p-Tau, and Aβ oligomers in the cerebral cortex, while TBG096 treatment significantly reduced the expression of these proteins in the brains of AD mice (Figure 5L,M and Figure S7E,F), respectively. This evidence concerns the gene MAPT and Alzheimer disease.